Bethesda, Md. ? The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), today announced the latest round of grant awards totaling more than $13.3 million to speed the development of innovative sequencing technologies that reduce the cost of DNA sequencing and expand the use of genomics in medical research and health care.
The millions of Americans afflicted with Type 1 and 2 Diabetes face many potential complications,including: heart and kidney disease; nerve damage and stroke; foot and skin problems; and gastrointestinal disorders and hypoglycemia.
Each year approximately 9,000 children and teenagers are diagnosed with cancer in the United States, with leukemia representing more than 30% of these cases. Thanks to research advances, the survival rate for the most common pediatric cancer, acute lymphocytic leukemia (ALL), has improved from a dismal 4 percent in the 1960s to more than 85 percent today. However, for children who survive cancer, the challenges continue long after the treatments are over.
UCB (Euronext Brussels: UCB) and Biogen Idec (NASDAQ: BIIB) today announced a global collaboration to jointly develop and commercialize CDP323 for the treatment of relapsing-remitting multiple sclerosis (MS) and other potential indications. CDP323 is an orally active small molecule alpha4-integrin inhibitor expected to enter Phase II clinical trials next year.
The developmental oral therapy FTY720 (fingolimod) has demonstrated sustained benefits over two years in patients suffering from relapsing multiple sclerosis (MS), indicating that it could provide an important new option for treating this disabling neurological disease estimated to affect more than 2.5 million people worldwide.
A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis.
Some people out there wonder why people pay out money on expensive contact lenses or expensive glasses. If you?ve never worn glasses or contact lenses, then chances are that you have good eyesight. In contrast, those that don?t have good vision will need to get either contact lenses or glasses in order to have near perfect vision.
Indicated in low septic conditions, with expressions of general physical depravity; disorganization of the blood, refusing to form clots; jaundice with great prostration. Most useful in all fevers of a malignant type, as yellow fever, malignant scarlet fever, haemorrhagic measles, malarial fevers of tropical countries. Also in typhus, cerebro-spinal meningitis, diphtheria with oozing of blood from the orifices (mouth and anus); ulcerations of the stomach; jaundice with dark, scanty urine and oozing of blood from the rectum; haemorrhage from the kidneys after scarlet fever.
Indicated in spasmodic affections (chorea), convulsive seizures (puerperal, epilepsy, convulsions of children). Particularly useful when convulsions and other threatening symptoms appear after suppression or too early disappearance of the rash in eruptive fevers. Valuable in whooping cough; in all forms of diarrhoea (cholera) with violent cramps in abdomen and calves of legs; in gastric affections with violent vomiting cramping; in colics so severe that collapse seems imminent.
Indicated in fevers of malarial, catarrhal or eruptive character, with shivering; fever without thirst; unwillingness to be disturbed; sense of paralytic weakness in the limbs. In catarrhal conditions, including hay fever and la grippe, with watery discharge, dullness of head, dizziness, chilliness, and neuralgia, and hysteria, passing off with the appearance of frequent and copious emissions of limpid urine. Diarrhoea from fright. Cerebro-spinal meningitis. Headaches with moderate vertigo. Post-diphtheritic paralysis of the throat.